Abstract
Purpose
To study the clinical profile, treatment, and visual outcome of patients with Coats disease in India.
Methods
This was a cross-sectional, observational hospital-based study of patients diagnosed with Coats disease during a 10-year period using an electronic medical record system.
Results
We identified 675 patients with Coats disease with a prevalence rate of 0.025%. The mean age of the patients was 16.8 years (median, 12 years). Majority were males (75%) with unilateral presentation (98%) in first decade of life (n = 309, 46%). The most common presentation was foveal exudation (stage 2B, n = 161, 23.3%), followed by exudative retinal detachment—extrafoveal (stage 3A1, n = 143, 20.7%), and extrafoveal exudation (stage 2A, n = 136, 19.7%). Treatment modalities included observation (48 eyes, 17%), laser photocoagulation ± intravitreal bevacizumab/triamcinolone acetonide (n = 82, 29%), cryotherapy ± intravitreal bevacizumab/triamcinolone acetonide (n = 64, 23%), and surgical intervention (n = 86, 31%). Despite appropriate treatment, at mean follow-up of 16 months, there was no significant difference between presenting and final visual acuity (48% vs. 48%, p > 0.05). Using multivariate regression analysis, factors associated with poor visual outcome were younger age (< 0.001; − 0.02 to − 0.1), unilateral disease (0.04; − 0.68 to − 0.01), cataract (0.004; 0.13 to 0.69), retinal detachment (< 0.001; 0.49 to 0.82), and glaucoma (< 0.001; 0.34 to 0.94).
Conclusion
The most common clinical presentation of Coats disease in India is foveal exudation in first and second decade. At initial presentation, about half of the affected eyes had blindness and one-third underwent surgical intervention.
Similar content being viewed by others
References
Shields JA, Shields CL, Honavar SG, Demirci H (2001) Clinical variations and complications of coats disease in 150 cases: the 2000 Sanford Gifford memorial lecture. Am J Ophthalmol 131:561–571
Shields JA, Shields CL, Honavar SG et al (2001) Classification and management of coats disease: the 2000 proctor lecture. Am J Ophthalmol 131:572–583
Morris B, Foot B, Mulvihill A (2010) A population-based study of Coats disease in the United Kingdom I: epidemiology and clinical features at diagnosis. Eye (Lond) 24:1797–1801
Sen M, Shields CL, Honavar SG, Shields JA (2019) Coats disease: an overview of classification, management and outcomes. Indian J Ophthalmol 67:763–771
Shields CL, Udyaver S, Dalvin LA et al (2019) Coats disease in 351 eyes: analysis of features and outcomes over 45 years (by decade) at a single center. Indian J Ophthalmol 67:772–783
Rishi P, Rishi E, Uparkar M et al (2010) Coats’ disease: an Indian perspective. Indian J Ophthalmol 58:119–124
Ong SS, Buckley EG, McCuen BW 2nd et al (2017) Comparison of visual outcomes in coats’ disease: a 20-year experience. Ophthalmology 124:1368–1376
Al-Qahtani AA, Almasaud JM, Ghazi NG (2015) Clinical characteristics and treatment outcomes of coats disease in a Saudi Arabian population. Retina 35:2091–2099
Cebeci Z, Bayraktar Ş, Yılmaz YC et al (2016) Evaluation of follow-up and treatment results in coats’ disease. Turk J Ophthalmol 46:226–231
Daruich A, Matet A, Munier FL (2018) Younger age at presentation in children with coats disease is associated with more advanced stage and worse visual prognosis: a retrospective study. Retina 38:2239–2246
Rao GN, Khanna RC, Athota SM et al (2012) Integrated model of primary and secondary eye care for underserved rural areas: the L V Prasad Eye Institute experience. Indian J Ophthalmol 60:396–400
Das AV, Kammari P, Vadapalli R, Basu S (2020) Big data and the eyeSmart electronic medical record system - an 8-year experience from a three-tier eye care network in India. Indian J Ophthalmol 68:427–432
Donthineni PR, Kammari P, Shanbhag SS et al (2019) Incidence, demographics, types and risk factors of dry eye disease in India: electronic medical records driven big data analytics report I. Ocul Surf 17:250–256
World Health Organization (2008) Change the definition of blindness
Shields CL, Schoenberg E, Kocher K et al (2013) Lesions simulating retinoblastoma (pseudoretinoblastoma) in 604 cases: results based on age at presentation. Ophthalmology 120:311–316
Usmanov RH, Kivelä T (2014) Predicted Trends in the Incidence of Retinoblastoma in the Asia-Pacific Region. Asia Pac J Ophthalmol (Phila) 3:151–157
Mulvihill A, Morris B (2010) A population-based study of Coats disease in the United Kingdom II: investigation, treatment, and outcomes. Eye (Lond) 24:1802–1807
Liang T, Xu Y, Zhu X et al (2020) Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease. BMC Ophthalmol 20:178
Zhao Q, Peng XY, Chen FH et al (2014) Vascular endothelial growth factor in Coats’ disease. Acta Ophthalmol 92:e225-228
Feng J, Zheng X, Li B, Jiang Y (2017) Differences in aqueous concentrations of cytokines in paediatric and adult patients with Coats’ disease. Acta Ophthalmol 95:608–612
Dalvin LA, Udyaver S, Lim LS et al (2019) Coats disease: clinical features and outcomes by age category in 351 cases. J Pediatr Ophthalmol Strabismus 56:288–296
Yousef YA, ElRimawi AH, Nazzal RM et al (2020) Coats’ disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease. Medicine (Baltimore) 99:e19623
Char DH (2000) Coats’ syndrome: long term follow up. Br J Ophthalmol 84:37–39
Acknowledgements
The authors wish to acknowledge the support of our Department of eyeSmart EMR & AEye team specially Mr. Ranganath Vadapalli and Mr. Mohammad Pasha.
Funding
This work was supported by an unrestricted departmental grant from Hyderabad Eye Research Foundation, Hyderabad, India.
Author information
Authors and Affiliations
Contributions
The corresponding author states that authorship credit of this manuscript was based on (1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; (2) drafting the article or revising it critically for important intellectual content; and (3) final approval of the version to be published. All listed authors met conditions 1, 2, and 3. All persons designated as authors qualify for authorship, and all those who qualify are listed. Each author has participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
This study was approved by the Institutional Review Board at L V Prasad Eye Institute (Ethics Ref No. LEC-BHR-R-06-21-708).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Dorji, P., Raval, V., Jalali, S. et al. Coats disease in India: clinical presentation and outcome in 675 patients (690 Eyes). Int Ophthalmol 43, 531–540 (2023). https://doi.org/10.1007/s10792-022-02451-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02451-x